|
Volumn 3, Issue 1, 2007, Pages 1-
|
Targeted therapy in colorectal cancer: Inequality of care between those who have and those who have not
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CETUXIMAB;
CANCER ADJUVANT THERAPY;
COLORECTAL CANCER;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG TARGETING;
EDITORIAL;
HEALTH CARE COST;
HEALTH CARE DISTRIBUTION;
HEALTH CARE QUALITY;
HEALTH CARE UTILIZATION;
HUMAN;
PATIENT PARTICIPATION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SURVIVAL TIME;
|
EID: 33847005431
PISSN: 17437555
EISSN: 17437563
Source Type: Journal
DOI: 10.1111/j.1743-7563.2006.00086.x Document Type: Editorial |
Times cited : (1)
|
References (0)
|